Boehringer Ingelheim · 3 hours ago
Principal Scientist, New Biological Entities PK/BA Group
Boehringer Ingelheim is seeking a highly motivated Principal Scientist – Drug Discovery Sciences Lead to join their NBE Pharmacokinetic/Bioanalytical group. The role involves identifying strategic scientific opportunities for NBE Pharmacokinetic impact and representing the pharmacokinetic discipline on multi-disciplinary drug discovery project teams.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Independently designs and performs scientific experiments with a predefined goal including developing new methodologies, protocols and or test procedures that contribute to core group/research goals and reflect expert knowledge; direct and oversee experimental design and results of staff in a matrixed environment. Support Oncology, Immunology, Cardiometabolic TAs and more
Contributes to defining R&D team goals and collaborates with scientists within and outside functional area in achieving them; Assumes departmental responsibility as representative on multiple project teams as DDS Lead and contributes to defining expertise-related aspects of overall program goals. Positively impacts project strategy and decision making using working knowledge of NBE bioanalytical, PK, and PK/PD modeling expertise
Prepares clear technical reports, external publications and oral presentations. Independently communicates results in the form of reports and/or presentations; Deliver updates to senior level management in context of overall project goals
Demonstrates expertise in a specific project-relevant area or technology; provides guidance and expertise to advance specific projects or evaluate and propose new technologies and concepts in support of multiple projects
Effectively collaborates with scientists within and outside functional area (e.g. therapeutic area biologists, protein engineering scientists)
Demonstrates collaborative excellence in a highly matrixed, virtual work environment
Develops broad knowledge in field of expertise, including the ability to interpret current literature relevant to R&D projects, and visibility outside of functional area
Actively supports recruitment, mentorship and development of scientific staff
Complies with all applicable regulations; ensures that work performed in area of responsibility is conducted in a safe and compliant manner; maintains proper records in accordance with SOPs and policies
Contributes to departmental administration; demonstrates fiscal responsibility with respect to cost of experiments, technology, external collaborations, and travel
Qualification
Required
Ph.D. from an accredited institution, or equivalent, with five-plus (5+) years of experience in a related field or equivalent (pharmacokinetics, pharmacology, biology, pharmaceutical sciences)
One (1) to three (3) years´ experience leading employees and projects is required
Demonstrates a broad knowledge of drug discovery
Candidate possesses strong practical knowledge of NBE pharmacokinetic principles including design and interpretation of PK studies, ligand binding assays and biodistribution concepts
Appropriate level of understanding of applicable regulations
Ability to communicate effectively both orally and in writing in an interdisciplinary environment
Must be legally authorized to work in the United States without restriction
Must be willing to take a drug test and post-offer physical (if required)
Must be 18 years of age or older
Preferred
Prior research experience in oncology, immunology, and/or cardio-metabolic diseases desirable; supporting these indications on cross-functional project teams
Preclinical PK/PD modeling experience highly desirable
Benefits
May be eligible for a role specific variable or performance-based bonus and or other compensation elements.
Company
Boehringer Ingelheim
Boehringer Ingelheim is a group of pharmaceutical companies that focuses on prescription medicines and animal health. It is a sub-organization of Boehringer Ingelheim.
Funding
Current Stage
Late StageLeadership Team
Recent News
BioWorld Financial Watch
2026-02-02
Mexico Business
2026-02-02
Company data provided by crunchbase